Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [05/06/2025 14:55 PDT] Novavax, Inc. (NASDAQ:NVAX), Down By 100% ($6.74) From $6.74 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [05/02/2025 07:10 PDT] NVAX Expected to Trade Down Short Term
• [04/29/2025 07:41 PDT] NVAX Expected to Trade Down Short Term
• [04/23/2025 10:29 PDT] Novavax, Inc. (NASDAQ:NVAX), Up By 100% ($5.39) From $5.39 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [04/11/2025 07:28 PDT] NVAX Expected to Trade Up After Bullish Patterns Develop
• [04/08/2025 07:58 PDT] NVAX Expected to Trade Up After Bullish Patterns Develop
• [04/02/2025 07:09 PDT] NVAX Expected to Trade Down After Bearish Patterns Develop
• [03/31/2025 10:29 PDT] Novavax, Inc. (NASDAQ:NVAX), Down By 100% ($7.57) From $7.57 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [03/31/2025 10:29 PDT] Novavax, Inc. (NASDAQ:NVAX), Down By 100% ($7.56) From $7.56 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [03/31/2025 10:29 PDT] Novavax, Inc. (NASDAQ:NVAX), Down By 100% ($7.92) From $7.92 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [03/26/2025 07:15 PDT] NVAX Expected to Trade Down Short Term
• [03/24/2025 07:03 PDT] NVAX Expected to Trade Down Short Term
• [03/12/2025 07:08 PDT] NVAX Expected to Trade Down After Bearish Patterns Develop
• [03/11/2025 07:14 PDT] NVAX Expected to Trade Up After Bullish Patterns Develop
• [03/10/2025 07:52 PDT] NVAX Expected to Trade Up After Bullish Patterns Develop